Abstract
Bile acids were first proposed as carcinogens in 1939. Since then, accumulated evidence has linked exposure of cells of the gastrointestinal tract to repeated high physiologic levels of bile acids as an important risk factor for gastrointestinal cancers. High exposure to bile acids may occur in a number of settings, but most importantly, is prevalent among individuals who have a high dietary fat intake.
A rapid effect on cells of high bile acid exposure is the generation of reactive oxygen species and reactive nitrogen species, disruption of the cell membrane and mitochondria, induction of DNA damage, mutation and apoptosis, and development of reduced apoptosis capability upon chronic exposure. Here, we review the substantial evidence of the mechanism of secondary bile acids and their role in colon cancer.
Similar content being viewed by others
Introduction
Bile Acids (BA) are normal components of the lumenal contents of the gastrointestinal (GI) tract, where they enable absorption of lipids, cholesterol, and fat-soluble vitamins. In essence, they act as a physiologic detergent and regulator of intestinal epithelial homeostasis in the gastrointestinal tract[1].
However, BAs, specifically lithocholic acid (LCA) - a secondary BA - also constitute a rare example of toxic endobiotics[2]. In fact, BAs were first proposed as a potential tumor-promoting agent in 1939[3].
At high physiologic concentrations, BAs can cause oxidative/nitrosative stress, DNA damage, apoptosis, and mutation[4]. Furthermore, frequently repeated and prolonged exposure of tissues to high physiological levels of BAs can lead to the generation of genomic instability, development of apoptosis resistance and, ultimately, cancer[4].
And since BAs are normal components of the luminal contents of the GI tract, finding the exact mechanism of their carcinogenic effect has become intriguing. Several factors have been found to increase levels of BAs: most importantly, a high dietary fat intake.
Our aim is to explain the correlation between the concentration of fecal secondary BAs -mainly deoxycholic acid (DOC) and LCA - and the colorectal cancer incidence that was highlighted by several epidemiological studies but whose molecular mechanism remain far from clear.
Furthermore, BAs were also found to be etiologic agents of other GI tract cancers, namely that of the esophagus[5], stomach[6], small intestine[7], liver[8], pancreas[9] and biliary tract[10].
Review
Biochemistry and physiology of secondary bile acids in the body
Primary BAs (cholic acid and chenodeoxycholic acid) are derived from cholesterol by a sequence of enzymatic reactions occurring mainly in the liver. Synthesis of a full complement of BAs requires 17 individual enzymes and occurs in multiple intracellular compartments that include the cytosol, endoplasmic reticulum (ER), mitochondria, and peroxisomes[11]. After synthesis, these BAs are conjugated with glycine or taurine and then excreted and stored in the gall bladder. In humans, BAs are largely re-absorbed in the terminal ileum by an active transport mechanism, but less than 5% of the BA pool enters the colon per day[12]. The BAs that enter the colon are metabolized by bacterial flora, where the primary BAs (cholic and chenodeoxycholic acid) are converted into the secondary BAs, DOC and LCA, respectively.
DOC is partly absorbed in the colon and enters the enterohepatic circulation, where it is conjugated in the liver and secreted in the bile[13]. LCA is fairly insoluble and little of it is reabsorbed[13]. Thus, the circulating BA pool (conjugated when it leaves the gallbladder, and then de-conjugated by action of bacterial enzymes after it enters the colon) is composed of about 30 to 40% each of cholic acid and chenodeoxycholic acid, about 20 to 30% of DOC, and less than 5% of LCA[14].
BAs are amphipathic and many of their properties are related to their amphipathic nature[15]. Their amphipathic nature enables them to get involved in emulsification and digestion of dietary fats; yet, levels above those that are physiologic are potentially membrane damaging.
Factors that change secondary bile acids levels
Almost 40 years ago, Berg was the first to make the observation that CRC (colorectal cancer) risk was higher among descendants of individuals in low-risk populations after moving to developed countries and converting to a Western-type diet that is rich in red meat and saturated fatty acids[16]. This was also consistent with a prospective cohort study that investigated 55,487 Danish middle-aged men and women and suggested that adherence to recommendations for five lifestyle factors (physical activity, smoking, waist circumference, alcohol intake and diet) may indeed considerably reduce CRC risk[17].
Prolonged, high consumption of red meat and saturated fatty acids were found to increase CRC risk. In their case control study, Bayerdorffer et al.[18] confirmed that DOC (Doxycholic acid) levels were significantly higher in the sera of patients with colorectal adenomas. Later, Bayerdorffer et al.[19] found that this positive association between DCA in the serum and colorectal adenomas was highest in the unconjugated fraction, which originates directly from the colon. High fat diets stimulate bile discharge, hence they increase the concentration of BAs above physiologic levels[20]. Population-based studies have shown that subjects who consume high-fat and high-beef foods display elevated levels of fecal secondary BAs, mostly DOC and LCA, as do patients diagnosed with colonic carcinomas[12, 13]. Results of such studies, however, are not very coherent due to difficulties in accurately measuring secondary BA levels in their different forms. Such incoherencies transpired because only levels of free LCA were measured, when most of LCA is in sulphated form. The increase in DOC and LCA reflects increased production of BAs in order to emulsify the increased level of dietary fat. Consequently, elevated secondary BA levels would alter the growth of intestinal epithelium, thus acting as tumor promoters[21]. Add to that, nicotine from smoking can interact synergistically in colon cells to increase oxidative stress and DNA damage[22].
Conversely, diets rich in vegetables and fruits are linked to a decreased CRC incidence. Dietary fibers (from vegetables and fruits) can bind to LCA and aid in its excretion in stool[23]; as such, fibers can protect against colon cancer. Not only fibers play a protective role, but vitamin D and high dietary Calcium supplementation also inhibits colon carcinogenesis induced by either high-fat diets or intrarectal instillation of LCA[24].
LCA activates vitamin D receptor, which may activate a feed-forward catabolic pathway that leads to the detoxification of LCA. Whereas, high dietary calcium leads to the formation of insoluble calcium soaps, this in turn decreases the concentration of free BAs in the intestinal lumen that ultimately may protect against formation of colon cancer[25].
Secondary bile acids and the plasma membrane
An essential constituent of plasma membrane is cholesterol, which rigidifies the membrane and is an important structural component of membrane microdomains[26]. Due to the fact that BAs are cholesterol derivatives with detergent properties, BAs may alter the stability of the membrane lipid bilayer[27]. In fact, BAs with increased hydrophobicity have a greater capacity to perturb the structure of, or partly digest, cell membranes[28]. Secondary BAs (DOC and LCA) also increased paracellular permeability in a dose-related manner, with LCA exerting more potent effects than DOC[29]. When present in high concentrations, secondary BAs, cause unspecific cell membrane damage resulting in focal destruction of intestinal epithelium (Payne, 2008[4]). Worse yet, subsequent repair mechanisms involving inflammatory reactions and hyperproliferation of undifferentiated cells would then increase the risk of transition into a precancerous state. Hyperproliferation of the colorectal mucosa is regarded as an early step in colorectal tumorigenesis[30].
In the colonic epithelium, high secondary BA concentrations induce cell proliferation by activating epidermal growth factor receptors (EGFRs) and post-EGFR/ERK (extracellular signal-regulated kinase) signaling[31]. In addition, BA-induced hyperproliferation can occur through the activity of protein kinase C (PKC), which can be activated downstream of the EGFR or by membrane perturbations[32].
Bile acids and nuclear receptors
Nuclear receptors (NRs) are transcription factors that act as sensors of dietary and endogenous molecules, translating nutritional and hormonal stimuli into transcriptional programs[33]. Recently, it has become apparent that nuclear BA receptors FXR, vitamin D receptor (VDR) and pregnane X receptor (PXR)/steroid xenobiotic receptor (SXR) play an important role in protecting against carcinogenic effects of BAs by activating transcriptional programs aimed at coordinating the control of BA uptake, detoxification, and basolateral secretion[34]. FXR, a member of the nuclear receptor superfamily, responds to BAs as physiological ligands[35]. FXR has a key role in activating pathways that maintain BA homeostasis. FXR protects against intestinal tumorigenesis, possibly by a mechanism involving induction of apoptosis[36].
Vitamin D deficiency is a known major risk factor for colorectal cancer[ bile acids colorectal cancer deoxycholic acid epidermal growth factor receptors endoplasmic reticulum ERK, extracellular signal-regulated kinase gastrointestinal lithocholic acid nuclear receptors protein kinase C pregnane X receptor reactive nitrogen species reactive oxygen species steroid xenobiotic receptor vitamin D receptor. Fiorucci S, Cipriani S, Mencarelli A, Renga B, Distrutti E, Baldelli F: Counter-regulatory role of bile acid activated receptors in immunity and inflammation. Curr Mol Med. 2010, 10: 579-595. Hofmann AF: Detoxification of lithocholic acid, a toxic bile acid: relevance to drug hepatotoxicity. Drug Metab Rev. 2004, 36: 703-722. 10.1081/DMR-200033475. Cook JW, Kennaway EL, Kennaway NM: Production of tumors in mice by deoxycholic acid. Nature. 1940, 145: 627- Payne CM, Bernstein C, Dvorak K, Bernstein H: Hydrophobic bile acids, genomic instability, Darwinian selection, and colon carcinogenesis. Clin Exp Gastroenterol. 2008, 1: 19-47. Dvorak K, Payne CM, Chavarria M, Ramsey L, Dvorakova B, Bernstein H, Holubec H, Sampliner RE, Guy N, Condon A, Bernstein C, Green SB, Prasad A, Garewal HS: Bile acids in combination with low pH induce oxidative stress and oxidative DNA damage: relevance to the pathogenesis of Barrett’s oesophagus. Gut. 2007, 56: 763-771. 10.1136/gut.2006.103697. Dixon MFMN, Neville PM, Moayyedi P, Axon AT: Bile reflux gastritis and intestinal metaplasia at the cardia. Gut. 2002, 51: 351-355. 10.1136/gut.51.3.351. Ross RK, Hartnett NM, Bernstein L, Henderson BE: Epidemiology of adenocarcinomas of the small intestine: is bile a small bowel carcinogen?. Br J Cancer. 1991, 63: 143-145. 10.1038/bjc.1991.29. Ohtaki YHT, Hiramatsu K, Kanitani M, Ohshima T, Nomura M, Wakita H, Aburada M, Miyamoto KI: Deoxycholic acid as an endogenous risk factor for hepatocarcinogenesis and effects of gomisin A, a lignan component of Schizandra fruits. Anticancer Res. 1996, 16: 751-755. Adachi TTY, Kuroki T, Mishima T, Kitasato A, Fukuda K, Tsutsumi R, Kanematsu T: Bile-reflux into the pancreatic ducts is associated with the development of intraductal papillary carcinoma in hamsters. J Surg Res. 2006, 136: 106-111. 10.1016/j.jss.2006.04.025. Komichi D, Tazuma S, Nishioka T, Hyogo H, Chayama K: Glycochenodeoxycholate plays a carcinogenic role in immortalized mouse cholangiocytes via oxidative DNA damage. Free Radic Biol Med. 2005, 39: 1418-1427. 10.1016/j.freeradbiomed.2005.07.005. Björkhem I, Eggertsen G: Genes involved in initial steps of bile acid synthesis. Curr Opin Lipidol. 2001, 12: 97-103. 10.1097/00041433-200104000-00002. Nagengast FM, Grubben MJ, van Munster IP: Role of bile acids in colorectal carcinogenesis. Eur J Cancer. 1995, 31A: 1067-1070. Hofmann AF, Cravetto C, Molino G, Belforte G, Bona B: Simulation of the metabolism and enterohepatic circulation of endogenous deoxycholic acid in humans using a physiologic pharmacokinetic model for bile acid metabolism. Gastroenterology. 1987, 93: 693-709. Hofmann AF: The Continuing Importance of Bile Acids in Liver and Intestinal Disease. Arch Intern Med. 1999, 159: 2647-2658. 10.1001/archinte.159.22.2647. Hofmann AF, Rods AA: Physicochemical properties of bile acids and their relationship to biological properties: an overview of the problem. J Lipid Res. 1984, 25: 1477-1489. Berg A: Nutrition, development, and population growth. Popul Bull. 1973, 29: 3-37. Kirkegaard H, Johnsen NF, Christensen J: Association of adherence to lifestyle recommendations and risk of colorectal cancer: a prospective Danish cohort study. BMJ. 2010, 341: c5504-10.1136/bmj.c5504. Bayerdörffer E, Mannes GA, Richter WO, Ochsenkühn T, Wiebecke B, Köpcke W, Paumgartner G: Increased serum deoxycholic acid levels in men with colorectal adenomas. Gastroenterology. 1993, 104: 145-151. Bayerdörffer E, Mannes GA, Ochsenkühn T, Dirschedl P, Wiebecke B, Paumgartner G: Unconjugated secondary bile acids in the serum of patients with colorectal adenomas. Gut. 1995, 36: 268-273. 10.1136/gut.36.2.268. Behar J: Physiology and Pathophysiology of the Biliary Tract: The Gallbladder and Sphincter of Oddi. Rev ISRN Physiol. 2013, 2013: Article ID 837630- Pai R, Tarnawski AS, Tran T: Deoxycholic Acid Activates -Catenin Signaling Pathway and Increases Colon Cell Cancer Growth and Invasiveness. Mol Biol Cell. 2004, 15: 2156-2163. 10.1091/mbc.E03-12-0894. Crowley-Weber CL, Dvorakova K, Crowley C, Bernstein H, Bernstein C, Garewal H, Payne CM: Nicotine increases oxidative stress, activates NF-kappaB and GRP78, induces apoptosis and sensitizes cells to genotoxic/xenobiotic stresses by a multiple stress inducer, deoxycholate: relevance to colon carcinogenesis. Chem Biol Interact. 2003, 145: 53-66. 10.1016/S0009-2797(02)00162-X. Jenkins D, Wolever TM, Rao AV, Hegele RA, Mitchell SJ, Ransom TP, Boctor DL, Spadafora PJ, Jenkins AL, Mehling C, Relle LK, Connelly PW, Story JA, Furumoto EJ, Corey P, Wursch P: Effect on blood lipids of very high intakes of fiber in diets low in saturated fat and cholesterol. N Engl J Med. 1993, 329: 21-26. 10.1056/NEJM199307013290104. Newmark HL, Yang K, Kurihara N, Fan K, Augenlicht LH, Lipkin M: Western-style diet-induced colonic tumors and their modulation by calcium and vitamin D in C57Bl/6 mice: a preclinical model for human sporadic colon cancer. Carcinogenesis. 2009, 30: 88-92. Lorenzen JK, Nielsen S, Holst JJ, Tetens I, Rehfeld JF, Astrup A: Effect of dairy calcium or supplementary calcium intake on postprandial fat metabolism, appetite, and subsequent energy intake. Am J Clin Nutr. 2007, 85: 678-687. Jean-Louis S, Akare S, Ali MA, Mash EA, Meuillet E, Martinez JD: Deoxycholic Acid Induces Intracellular Signaling through Membrane Perturbations. J Biol Chem. 2006, 281: 14948-14960. 10.1074/jbc.M506710200. Chen X, Resh MD: Cholesterol Depletion from the Plasma Membrane Triggers Ligand-independent Activation of the Epidermal Growth Factor Receptor. J Biol Chem. 2002, 227: 49631-49637. Sagawa H, Tazuma S, Kajiyama G: Protection against hydrophobic bile salt-induced cell membrane damage by liposomes and hydrophilic bile salts. Am J Physiology. 1993, 264: G835-G839. Stenman LK, Holma R, Korpela R: High-fat-induced intestinal permeability dysfunction associated with altered fecal bile acids. World J Gastroenterol. 2012, 18: 923-929. 10.3748/wjg.v18.i9.923. Ochsenkühn T, Bayerdörffer E, Meining A, Schinkel M, Thiede C, Nüssler V, Sackmann M, Hatz R, Neubauer A, Paumgartner G: Colonic mucosal proliferation is related to serum deoxycholic acid levels. Cancer. 2000, 85: 1664-1669. Hylemon PB, Zhou H, Dent P: Bile acids as regulatory molecules. J Lipid Res. 2009, 50: 1509-1520. 10.1194/jlr.R900007-JLR200. Rao YP, Stravitz RT, Vlahcevic ZR, Gurley EC, Sando JJ, Hylemon PB: Activation of protein kinase C alpha and delta by bile acids: correlation with bile acid structure and diacylglycerol formation. J Lipid Res. 1997, 38: 2446-2454. D’Errico I, Moschetta A: Nuclear receptors, intestinal architecture and colon cancer: an intriguing link. Cell Mol Life Sci. 2008, 65: 1523-1543. 10.1007/s00018-008-7552-1. Bernstein H, Bernstein C, Payne CM, Dvorak K: Bile acids as endogenous etiologic agents in gastrointestinal cancer. World J Gastroenterol. 2009, 15: 3329-3340. 10.3748/wjg.15.3329. Chen WD, Wang YD, Meng Z, Zhang L, Huang W: Nuclear bile acid receptor FXR in the hepatic regeneration. Biochim Biophys Acta. 2011, 1812: 888-892. 10.1016/j.bbadis.2010.12.006. Maran RR, Thomas A, Roth M, Sheng Z, Esterly N, Pinson D, Gao X, Zhang Y, Ganapathy V, Gonzalez FJ, Guo GL: Farnesoid X receptor deficiency in mice leads to increased intestinal epithelial cell proliferation and tumor development. J Pharmacol Exp The. 2009, 328: 469-477. 10.1124/jpet.108.145409. Makishima M, Lu TT, **e W, Whitfield GK, Domoto H, Evans RM, Haussler MR, Mangelsdorf DJ: Vitamin D receptor as an intestinal bile acid sensor. Science. 2002, 296: 1313-1316. 10.1126/science.1070477. Zhang B, **e W, Krasowski MD: PXR: a xenobiotic receptor of diverse function implicated in pharmacogenetics. Pharmacogenomics. 2008, 9: 1695-1709. 10.2217/14622416.9.11.1695. Staudinger JL, Goodwin B, Jones SA, Hawkins-Brown D, MacKenzie KI, LaTour A, Liu Y, Klaassen CD, Brown KK, Reinhard J, Willson TM, Koller BH, Kliewer SA: The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity. Proc Natl Acad Sci U S A. 2001, 98: 3369-3374. 10.1073/pnas.051551698. Modica S, Murzilli S, Salvatore L, Schmidt DR, Moschetta A: Nuclear bile acid receptor FXR protects against intestinal tumorigenesis. Res Cancer. 2008, 68: 9589-9594. 10.1158/0008-5472.CAN-08-1791. Tsioulias G, Godwin TA, Goldstein MF, McDougall CJ, Ngoi SS, DeCosse JJ, Rigas B: Loss of colonic HLA antigens in familial adenomatous polyposis. Cancer Res. 1992, 52: 3449-3452. Arvind P, Papavassiliou ED, Tsioulias GJ, Duceman BW, Lovelace CI, Geng W, Staiano-Coico L, Rigas B: Lithocholic acid inhibits the expression of HLA class I genes in colon adenocarcinoma cells. Differential effect on HLA-A, −B and -C loci. Mol Immunol. 1994, 31: 607-614. 10.1016/0161-5890(94)90168-6. Bernstein H, Bernstein C, Payne CM, Dvorakova K, Garewal H: Bile acids as carcinogens in human gastrointestinal cancers. Mutat Res. 2005, 589: 47-65. 10.1016/j.mrrev.2004.08.001. Reinehr R, Becker S, Eberle A, Grether-Beck S, Haussinger D: Involvement of NADPH oxidase isoforms and Src family kinases in CD95-dependent hepatocyte apoptosis. J Biol Chem. 2005, 280: 27179-27194. 10.1074/jbc.M414361200. Strauch ED, Bass BL, Rao JN, Vann JA, Wang JY: NF-kappaB regulates intestinal epithelial cell and bile salt-induced migration after injury. Ann Surg. 2003, 237: 494-501. Karin M: NF-kappaB as a critical link between inflammation and cancer. Cold Spring Harb Perspect Biol. 2009, 1: a000141- Glinghammar B, Inoue H, Rafter JJ: Deoxycholic acid causes DNA damage in colonic cells with subsequent induction of caspases, COX-2 promoter activity and the transcription factors NF-kB and AP-1. Oxford J. 2002, 23: 839-845. Powolny A, Xu J, Loo G: Deoxycholate induces DNA damage and apoptosis in human colon epithelial cells expressing either mutant or wild-type p53. Int J Biochem Cell Biol. 2001, 33: 193-203. 10.1016/S1357-2725(00)00080-7. Armaghany T, Wilson JD, Chu Q, Mills G: Genetic Alterations in Colorectal Cancer. Gastrointest Cancer Res. 2012, 5: 19-27. Degirolamo C, Modica S: Palasciano G Bile acids and colon cancer: Solving the puzzle with nuclear receptors. Trends Mol Med. 2011, 17: 564-572. 10.1016/j.molmed.2011.05.010. Narahara H, Tatsuta M, Iishi H, Baba M, Uedo N, Sakai N, Yano H, Ishiguro S: K-ras point mutation is associated with enhancement by deoxycholic acid of colon carcinogenesis induced by azoxymethane, but not with its attenuation by all-trans-retinoic acid. Int J Cancer. 2000, 88: 157-161. 10.1002/1097-0215(20001015)88:2<157::AID-IJC2>3.0.CO;2-B. Bernstein H, Holubec H, Warneke JA, Garewal H, Earnest DL, Payne CM, Roe DJ, Cui H, Jacobson EL, Bernstein C: Patchy field defects of apoptosis resistance and dedifferentiation in flat mucosa of colon resections from colon cancer patients. Ann Surg Oncol. 2002, 9: 505-517. 10.1007/BF02557276. Perez MJ, Briz O: Bile-acid-induced cell injury and protection. World J Gastroenterol. 2009, 15: 1677-1689. 10.3748/wjg.15.1677. Yui S, Kanamoto R, Saeki T: Biphasic regulation of cell death and survival by hydrophobic bile acids in HCT116 cells. Nutr Cancer. 2009, 61: 374-380. 10.1080/01635580802582744. Lowe SW, Lin AW: Apoptosis in cancer. Oxford J. 1999, 21: 485-495. Yui S, Kanamoto R, Saeki T: Deoxycholic acid can induce apoptosis in the human colon cancer cell line HCT116 in the absence of Bax. Nutr Cancer. 2007, 60: 91-96. 10.1080/01635580701525893. Krajewska M, Moss SF, Krajewski S, Song K, Holt PR, Reed JC: Elevated expression of Bcl-X and reduced Bak in primary colorectal adenocarcinomas. Cancer Res. 1996, 56: 2422-2427. The authors declare that they have no competing interests. HA drafted the manuscript, AS and DM participated in the design and coordination of the study. All authors read and approved the final manuscript. Below are the links to the authors’ original submitted files for images.
Open Access
This article is published under license to BioMed Central Ltd. This is an Open Access article is distributed under the terms of the Creative Commons Attribution License (
https://creativecommons.org/licenses/by/2.0
), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Ajouz, H., Mukherji, D. & Shamseddine, A. Secondary bile acids: an underrecognized cause of colon cancer.
World J Surg Onc 12, 164 (2014). https://doi.org/10.1186/1477-7819-12-164 Received: Accepted: Published: DOI: https://doi.org/10.1186/1477-7819-12-164Abbreviations
References
Author information
Authors and Affiliations
Corresponding author
Additional information
Competing interests
Authors’ contributions
Authors’ original submitted files for images
Rights and permissions
About this article
Cite this article
Keywords